Follow
Dr. Keerti Vishwakarma
Dr. Keerti Vishwakarma
PhD
Verified email at nirmauni.ac.in
Title
Cited by
Cited by
Year
Molecular modelling of quinoline derivatives as telomerase inhibitors through 3D-QSAR, molecular dynamics simulation, and molecular docking techniques
K Vishwakarma, H Bhatt
Journal of Molecular Modeling 27, 1-16, 2021
122021
Telomerase: A prominent oncological target for development of chemotherapeutic agents
K Vishwakarma, R Dey, H Bhatt
European Journal of Medicinal Chemistry 249, 115121, 2023
102023
Synthesis and biological evaluation of β-carboline derivatives as an anxiolytic agents
RSPPKS Keerti Vishwakarma, Shilpi Jain, Harish Rajak
Der Pharma Chemica 6 ((1)), 472-476, 2014
32014
The retroactive and future potentials of Aurora kinases in the treatment of cancer
H Bhatt, K Vishwakarma, S Shaw
Protein Kinase Inhibitors, 323-360, 2022
2022
FORCED DEGRADATION STUDY FOR ESTIMATION OF RELATED SUBSTANCES AND DEGRADANTS IN ALLOPURINOL TABLET AND ITS METHOD VALIDATION USING RP-HPLC
PKS Manjri Kharia, Keerti Vishwakarma
Indo American Journal of Pharmaceutical Research 8 (06), 1367-1373, 2018
2018
SCREENING OF ANTICONVULSANT ACTIVITY OF SOME NEWLY SYNTHESIZED PHTHALIMIDE DERIVATIVES
S Tiwari, K Vishwakarma, N Jain, PK Singour
Pharma Science Monitor 5 (3), 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–6